The $573 million settlement resolves opioid-related consumer protection charges arising from McKinsey’s role in developing marketing plans for pharmaceutical companies that contributed to the nation’s opioid crisis.The settlement includes more than $12 million to be used for abatement of the opioids epidemic in Maryland. Source: Maryland Attorney General